Trial intelligence / Profile preview

Sodium hydroxybutyrate vs propofol for anesthesia induction in neurosurgery

ChiCTR2500110811Phase 4Not yet recruiting

Sponsor
Beijing Sanbo Brain Hospital
Start
May 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of sodium oxybate (2 arms), sponsored by Beijing Sanbo Brain Hospital. Primary endpoint: Change in mean arterial pressure before intubation vs baseline. Planned start May 2025; status: not yet recruiting.

02

Drugs

sodium oxybate

Beyond the preview

Go deeper on ChiCTR2500110811.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500110811.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call